A systematic approach to identifying urothelial cells likely to be polysomic by fluorescence in situ hybridization

Analytical and Quantitative Cytology and Histology

Volumn 27, Issue 6, 2005, Pages 317-322

  Kipp, Benjamin R ^a,b,c   Barr Fritcher, Emily G ^a,b   Del Rosario, Kristina M ^a,b   Stevens, Carole L ^a,b   Sebo, Thomas J ^a,d,e   Halling, Kevin C ^a,b,d,f  

^a MAYO CLINIC   (United States)

^b Molecular Cytology and Imaging Laboratory   (United States)

^c Mayo Clinic   (United States)

^d Department of Laboratory Medicine and Pathology ^*  (United States)

^e Spedali Civili   (Italy)

^f Clinical Molecular Genetics Laboratory   (United States)

Author keywords

Hybridization in situ, fluorescence; Morphometry; Urine; Urothelium; UroVysion

Indexed keywords

ADULT; AGED; ARTICLE; AUTOMATION; CELL NUCLEUS; CELL SHAPE; CELL STRUCTURE; CHROMATIN STRUCTURE; CHROMOSOME ABERRATION; CYTOLOGY; EQUIPMENT; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; MORPHOMETRICS; POLYSOME; PRIORITY JOURNAL; URINALYSIS; UROTHELIUM;

ADULT; AGED; AGED, 80 AND OVER; ANEUPLOIDY; FEMALE; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MALE; MIDDLE AGED; UROLOGIC NEOPLASMS; UROTHELIUM;

EID: 29144504310     PISSN: 08846812     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. Sokolova IA, Halling KC, Jenkins RB, Burkhardt HM, Meyer RG, Seelig SA, King W: The development of multitarget, multicolor fluorescence in situ hybridization assay for the detection of urothelial carcinoma in urine. J Mol Diagn 2000;2:116-123
2. Bubendorf L, Grilli B, Sauter G, Mihatsch MJ, Gasser TC, Dalquen P: Multiprobe FISH for enhanced detection of bladder cancer in voided urine specimens and bladder washings. Am J Clin Pathol 2001;116:79-86
3. Halling KC, King W, Sokolova IA, Karnes RJ, Meyer RG, Powell EL, Sebo TJ, Cheville JC, Clayton AC: A comparison of BTA stat, hemoglobin dipstick, telomerase, and Vysis UroVysion assays for the detection of urothelial carcinoma in urine. J Urol 2002;167:2001-2006
4. Halling KC: Vysis UroVysion for the detection of urothelial carcinoma. Expert Rev Mol Diagn 2003;3:507-519
5. Sarosdy MF, Schellhammer P, Bokinsky G, Kahn P, Chao R, Yore L, Zadra J, Burzon D: Clinical evaluation of multi-target fluorescent in situ hybridization assay for the detection of bladder cancer. J Urol 2002;168:1950-1954
6. Skacel M, Fahmy M, Brainard JA, Pettay JD, Biscotti CV, Liou LS, Procop GW, Jones JS, Ulchaker J, Zippe CD, Tubbs RR: Multitarget fluorescence in situ hybridization assay detects transitional cell carcinoma in the majority of patients with bladder cancer and atypical or negative urine cytology. J Urol 2003;169:2101-2105
7. Veeramachaneni R, Nordberg ML, Shi R, Herrera GA, Turbat-Herrera EA: Evaluation of fluorescence in situ hybridization as an ancillary tool to urine cytology in diagnosing urothelial carcinoma. Diagn Cytopathol 2003;28:301-307
8. Halling KC, King W, Sokolova IA, Meyer RG, Burkhardt HM, Halling AC, Cheville JC, Sebo TJ: A comparison of cytology and fluorescence in situ hybridization for the detection of urothelial carcinoma. J Urol 2000;164:1768-1775
9. DeMay R: Urine. In The Art and Science of Cytopathology. Chicago, ASCP Press, 1999, p 391